837
Views
45
CrossRef citations to date
0
Altmetric
Original

The Effects of Stressful Life Events on the Course of Multiple Sclerosis: A Review

, , &
Pages 315-335 | Received 02 Apr 2008, Accepted 01 Jul 2008, Published online: 07 Jul 2009

REFERENCES

  • Ackerman K. D., Heyman R., Rabin B. S., Anderson B. P., Houck P. R., Frank E., et al. Stressful life events precede exacerbations of multiple sclerosis. Psychosomatic Medicine 2002; 64: 916–920
  • Ackerman K. D., Martino M., Heyman R., Moyna N. M., Rabin B. S. Immunologic response to acute psychological stress in MS patients and controls. Journal of Neuroimmunology 1996; 68: 85–94
  • Ackerman K. D., Martino M., Heyman R., Moyna N. M., Rabin B. S. Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosomatic Medicine 1998; 60: 484–491
  • Aikens J. E., Fischer J. S., Namey M., Rudick R. A. A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis. Journal of behavioral medicine 1997; 20: 433–445
  • Bartholomew K., Horowitz L. M. Attachment styles among young adults: A test of a four-category model. Journal of Personality and Social Psychology 1991; 61: 226–244
  • Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., Brueck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 123: 1174–1183
  • Brickner R. M., Simons D. J. Emotional stress in relation to attacks of multiple sclerosis. Research Publications—Association for Research in Nervous and Mental Disease 1950; 28: 143–149
  • Brown G. W., Harris T. O. The Bedford College Life-Events and Difficulties Schedule: directory of contextual threat ratings of events, et al. Bedford College, University of London, London 1978
  • Brown R. F., Tennant C. C., Dunn S. M., Pollard J. D. A review of stress-relapse interactions in multiple sclerosis: Important features and stress-mediating and-moderating variables. Multiple Sclerosis 2005; 11: 477–484
  • Brown R. F., Tennant C. C., Sharrock M., Hodgkinson S., Dunn S. M., Pollard J. D. Relationship between stress and relapse in multiple sclerosis: Part I. Important features. Multiple Sclerosis 2006; 12: 453–464
  • Buelow J. M. A correlational study of disabilities, stressors and coping methods in victims of multiple sclerosis. Journal of Neuroscience Nursing 1991; 23: 247–252
  • Buljevac D., Hop W. C., Reedeker W., Janssens A. C. J. W., Van Der Meché F. G. A., van Doorn P. A., et al. Self reported stressful life events and exacerbation in multiple sclerosis: prospective study. BMJ 2003; 9: 307–310
  • Burnfield A. Doctor-patient dilemmas in multiple sclerosis. Journal of Medical Ethics 1984; 10: 21–26
  • Charcot J. M. Leçons sur les maladies du système nerveux. Oeuvres complètes de J.M. Charcot, L. Bataille. Progrès medical, Paris 1892; 270–271
  • Chelmicka-Schorr E., Arnason B. G. Nervous system-immune system interactions and their role in multiple sclerosis. Annals of Neurology 1994; 36(suppl)29–32
  • Chwastiak L., Ehde D. M., Gibbons L. E., Sullivan M., Bowen J. D., Kraft G. H. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic study of a large community sample. American Journal of Psychiatry 2002; 159: 1862–1868
  • Confavreux C. Infections and the risk of relapse in multiple sclerosis. Brain 2002; 125: 933–934
  • Confavreux C., Suissa S., Saddier P., Bourdes V., Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis: Vaccines in multiple sclerosis study group. New England Journal of Medicine 2001; 344: 319–326
  • Correa S. G., Rodriguez-Galan M. C., Rivero V. E., Riera C. M. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain, Behavior, and Immunity 1998; 12: 134–148
  • Dalos N. P., Rabins P. V., Brooks B. R., O’Donnell P. Disease activity and emotional state in multiple sclerosis. Annals of Neurology 1983; 13: 573–577
  • Di Legge S., Piattella M. C., Pozzilli C., Pantano P., Caramia F., Pestalozza I. F., et al. Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis. Multiple Sclerosis 2003; 9: 302–306
  • Dohrenwend B. S., Krasnoff L., Askenasy A. R., Dohrenwend B. P. Exemplification of a method for scaling life events: The Peri Life Events Scale. Journal of Health and Social Behavior 1978; 19: 205–229
  • Esposito P., Gheorghe D., Kandere K., Pang X., Conally R., Jacobson S. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Research 2001; 888: 117–127
  • Fournier M., De Ridder D., Bensing J. Optimism and adaptation to chronic disease: The role of optimism in relation to self-care options of type 1 diabetes mellitus, rheumatoid arthritis and multiple sclerosis. British Journal of Health Psychology 2002; 7: 409–432
  • Franklin G. M., Nelson L. M., Heaton R. K., Burkes J. S., Thompson D. S. Stress and its relationship to acute exacerbations in multiple sclerosis. Journal of Neurological Rehabilitation 1988; 2: 7–11
  • Gasperini C., Grasso M. G., Fiorelli M., Millefiorini E., Morino S., Anzini A., et al. A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 1995; 59: 303–305
  • Ganster D. C., Victor B. The impact of social support on mental and physical health. British Journal of Medical Psychology 1988; 61: 17–36
  • Gilchrist A. C., Creed F. H. Depression, cognitive impairment and social stress in multiple sclerosis. Journal of Psychosomatic Research 1994; 38: 193–201
  • Goldberg D. P., Hillier V. F. A scaled version of the General Health Questionnaire. Psychological Medicine 1979; 9: 139–145
  • Goldsteen R. L., Counte M. A., Goldsteen K. Examining the relationship between health locus of control and the use of medical care services. Journal of Aging and Health 1994; 6: 314–335
  • Goodin D. S., Ebers G. C., Johnson K. P., Rodriguez M., Sibley W. A., Wolinsky J. S. The relationship of MS to physical trauma and psychological stress: Report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 1999; 52: 1737–1745
  • Grant I., Brown G. W., Harris T., McDonald W. I., Patterson T., Trimble M.R. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 1989; 52: 8–13
  • Henry J. P. Biological basis of the stress response. Integrative physiological and behavioral science 1992; 27: 66–83
  • Heesen C., Schulz H., Schmidt M., Gold S., Tessmer W., Schulz K. H. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain, Behaviour, and Immunity 2002; 16: 282–287
  • Helgeson V. S. Social support and quality of life. Quality of Life Research 2003; 12: 25–31
  • Holmes T. H., Rahe R. H. The social readjustment rating scale. Journal of Psychosomatic Research 1967; 11: 213–218
  • Janssens A. C., van Doorn P. A., de Boer J. B., Van Der Meche F. G., Passchier J., Hintzen R. Q. Perception of prognostic risk in patients with multiple sclerosis: The relationship with anxiety, depression, and disease-related distress. Journal of Clinical Epidemiology 2004; 57: 180–186
  • Karlidag R., Unal S., Evereklioglu C., Sipahi B., Er H., Yologlu S. Stressful life events, anxiety, depression and coping mechanisms in patients with Behcet's disease. Journal of the European Academy of Dermatology and Venereology 2003; 17: 670–675
  • Kiank C., Holtfreter B., Starke A., Mundt A., Wilke C., Schutt C. Stress susceptibility predicts the severity of immune depression and the failure to combat bacterial infections in chronically stressed mice. Brain, Behavior, and Immunity 2006; 20: 359–368
  • Kino T., Chrousos G. P. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. Journal of Endocrinology 2001; 169: 437–445
  • Kroencke D. C., Denney D. R., Lynch S. G. Depression during exacerbations in multiple sclerosis: The importance of uncertainty. Multiple Sclerosis 2001; 7: 237–242
  • Kuroda Y., Mori T., Hori T. Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Research Bulletin 1994; 34: 15–17
  • Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452
  • Lalive P. H., Burkhard P. R., Chofflon M. TNF-alpha and psychologically stressful events in healthy subjects: Potential relevance for multiple sclerosis relapse. Behavioral Neuroscience 2002; 116: 1093–1097
  • LaRocca N. G. Psychosocial factors in multiple sclerosis and the role of stress. Annals of the New York Academy of Sciences 1984; 436: 435–442
  • Lasar M., Kotterba S. Locus of control of patients with a phasic encephalomyelitis disseminate course. Schweiz Arch Neurol Psychiatr 1993; 144: 147–162
  • Lazarus R. S., Folkman S. Stress, Appraisal and Coping, et al. Springer, New York 1984
  • Lee I. T., Sheu W. H., Liau Y. J., Lin S. Y., Lee W. J., Lin C. C. Relationship of stressful life events, anxiety and depression to hyperthyroidism in an asian population. Hormone Research 2003; 6: 247–251
  • Lefcourt H. M. Internal versus external control of reinforcement: A review. Psychological Bulletin 1966; 65: 206–220
  • Levine S., Saltzman A. Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats. Brain, Behavior, and Immunity 1987; 1: 336–341
  • Lewis G., Pelosi A. J., Araya R., Dunn G. Measuring psychiatric disorder in the community: A standardized assessment for use by lay interviewers. Psychological Medicine 1992; 22: 465–486
  • Logsdail S. J., Callanan M. M., Ron M. A. Psychiatric morbidity in patients with clinically isolated lesions of the type seen in multiple sclerosis: A clinical and MRI study. Psychological Medicine 1988; 18: 355–364
  • Lynch S. G., Kroencke D. C., Denney D. R. The relationship between disability and depression in multiple sclerosis: The role of uncertainty, coping, and hope. Multiple Sclerosis, 7 2001; 411–416
  • Matos-Santos A., Lacerda Nobre E., Garcia Costa J., Nogueira P. J., Macedo A., Galvao-Teles A., et al. Relationship between the number and impact of stressful life events and the onset of Grave's disease and toxic nodular goitre. Clinical Endocrinology 2001; 55: 15–19
  • Mc Alpine D., Compston N. D. Some aspects of the natural history of multiple sclerosis. Quart Journal of Medicine 1952; 21: 135–167
  • McDonald W. I., Compston A., Edan G., Goodkin D., Hartung H. P., Lublin F. D., et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001; 50: 121–127
  • McIvor G. P., Riklan M., Reznikoff M. Depression in multiple sclerosis as a function of length and severity ofillness, age, remissions, and perceived social support. Journal of Clinical Psychology 1984; 40: 1028–1033
  • Mei-Tal V., Meyerowitz S., Engel G. L. The role of psychological process in somatic disorder: Multiple sclerosis. The emotional setting of illness onset and exacerbation. Psychosomatic Medicine 1970; 32: 67–86
  • Mitsonis C., Potagas C., Zouvelou V., Mantelos D., Mitropoulos P., Sfagos C. Correlation between stressful life events, anxiety and relapse in a female population with multiple sclerosis: A prospective study. Journal of Neurology 2005; 252(Supp l2)65
  • Mohr D. C., Dick L. P., Russo D., Pinn J., Boudewyn A. C., Likosky W., et al. The psychosocial impact of multiple sclerosis: Exploring the patient's perspective. Health Psychology 1999; 18: 376–382
  • Mohr D. C., Genain C. Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis. Journal of Psychosomatic Research 2004; 57: 155–158
  • Mohr D. C., Goodkin D. A., Bacchetti P., Boudewyn A. C., Huang L., Marrietta P., et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2000; 55: 55–61
  • Mohr D. C., Goodkin D. E., Islar J., Hauser S. L., Genain C. G. Treatment of depression is associated with suppression of non-specific and antigen-specific TH1 responses in multiple sclerosis. Archives of Neurology 2001; 58: 1081–1086
  • Mohr D. C., Goodkin D. E., Nelson S., Cox D., Weiner M. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosomatic Medicine 2002; 64: 803–809
  • Mohr D. C., Hart S. L., Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: A meta-analysis. BMJ 2004; 328: 731–733
  • Munck A., Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Annals of the New York Academy of Sciences 1994; 746: 115–130
  • Mundt C., Reck C., Backenstrass M., Kronmuller K., Fiedler P. Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. Journal of Affective Disorders 2000; 59: 23–30
  • Nisipeanu P., Korczyn A. D. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993; 43: 1311–1312
  • Noseworthy J. H., Lucchinetti C., Rodriguez M., Weinshenker B. G. Multiple sclerosis. New England Journal of Medicine 2000; 343: 938–952
  • O’Brien M. T. Multiple sclerosis: the relationship among self-esteem, social support, and coping behavior. Applied Nursing Research 1993; 6: 54–63
  • Pearce J. M. Historical descriptions of multiple sclerosis. European Neurology 2005; 54: 49–53
  • Pender M. P., Wolfe N. P. Prevention of autoimmune attack and disease progression in multiple sclerosis: Current therapies and future prospects. Internal Medicine Journal 2002; 32: 554–563
  • Philippopoulos G. S., Wittkower E. D., Cousineau A. The etiologic significance of emotional factors in onset and exacerbations of multiple sclerosis; a preliminary report. Psychosomatic Medicine 1958; 20: 458–474
  • Poser C. M. Physical trauma and psychological stress in the multiple sclerosis. Revista de neurologia 1980; 136: 807–814
  • Poser C. M. Trauma, stress and multiple sclerosis. Bulletin of the American Academy of Psychiatry of the Law 1981; 7: 209–217
  • Pratt R. T. An investigation of the psychiatric aspects of disseminated sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 1951; 14: 326–335
  • Rabins P. V., Brooks B. R., O’Donnell P., Pearlson G. D., Moberg P. J., Jubelt B. Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986; 109: 585–597
  • Rickards H. Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke. Journal of Neurology, Neurosurgery & Psychiatry 2005; 76: 48–52
  • Riether A.M. Anxiety in patients with multiple sclerosis. Seminars in Clinical Neuropsychiatry 1999; 4: 103–113
  • Rosenberg J. H., Shafor R. Fatigue in multiple sclerosis: A rational approach to evaluation and treatment. Current Neurology and Neuroscience Reports 2005; 5: 140–146
  • Sabatini U., Pozzilli C., Pantano P., Koudriavtseva T., Padovani A., Millefiorini E., et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biological Psychiatry 1996; 39: 970–975
  • Sadovnick A. D., Eisen K., Ebers G. C., Paty D. W. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193–1196
  • Sandyk R. Tryptophan availability and the susceptibility to stress in multiple sclerosis: A hypothesis. International Journal of Neuroscience 1996; 86: 47–53
  • Sibley W. A. Risk factors in multiple sclerosis: implications for pathogenesis. A multidisciplinary approach to myelin disease, G. Serlupi Crescenzi. Plenium Press, New York 1987; 227–232
  • Sibley W. A. Risk factors in multiple sclerosis. Multiple Sclerosis: Clinical And Pathogenetic Basis, C. S. Raine, H. F. McFarland, W. W. Tourtellotte. Chapman & Hall, London 1997; 141–148
  • Siegert R. J., Abernethy D. A. Depression in multiple sclerosis: A review. Journal of Neurology, Neurosurgery & Psychiatry 2005; 76: 469–475
  • Sospedra M., Martin R. Immunology of multiple sclerosis. Annual Review of Immunology 2005; 23: 683–747
  • Steinman L., Zamvil S. S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Annals of Neurology 2006; 60: 12–21
  • Stenager E. N., Stenager E., Koch-Henriksen N., Bronnum-Hansen H., Hyllested K, Jensen K. Suicide and multiple sclerosis: An epidemiological investigation. Journal of Neurology, Neurosurgery & Psychiatry 1992; 55: 542–545
  • Stewart D. C., Sullivan T. J. Illness behavior and the sick role in chronic disease. The case of multiple sclerosis. Social Science & Medicine 1982; 16: 1397–1404
  • Stuber M. L., Kazak A. E., et al. Predictors of posttraumatic stress symptoms in childhood cancer survivors. Pediatrics 1997; 100: 958–964
  • Schwartz C. E., Foley F. W., Rao S. M., Bernardin L. J., Lee H., Genderson M. W. Stress and course of disease in multiple sclerosis. Behavioral Medicine 1999; 25: 110–116
  • Schwartz C., Frohner R. Contribution of demographic, medical, and social support variables in predicting the mental health dimension of quality of life among people with multiple sclerosis. Health & Social Work 2005; 30: 203–212
  • Schwartz L., Kraft G. H. The role of spouse responses to disability and family environment in multiple sclerosis. American Journal of Physical Medicine & Rehabilitation 1999; 78: 525–532
  • Vukusic S., Hutchinson M., Hours M., Moreau T., Cortinovis–Tourniaire P., Adeleine P., et al. Pregnancy and multiple sclerosis: Clinical predictors of post-partum relapse. Brain 2004; 127: 1353–1360
  • Wassem R. A test of the relationship between health locus of control and the course of multiple sclerosis. Rehabilitation Nursing 1991; 16: 189–193
  • Warren K. G., Cockerill R. Emotional stress and coping in multiple sclerosis exacerbations. Journal of Psychosomatic Research 1991; 35: 37–47
  • Warren S., Greenhill S., Warren K. G. Emotional stress and the development of multiple sclerosis: Case-control evidence of a relationship. Journal of Chronic Diseases 1982; 35: 821–831
  • Wrosch C., Scheier M. F. Personality and quality of life: The importance of optimism and goal adjustment. Quality of Life Research 2003; 12: 59–72
  • Zappulla J. P., Arock M., Mars L. T., Liblau R. S. Mast cells: New targets for multiple sclerosis therapy?. Journal of Neuroimmunology 2002; 131: 5–20
  • Zeldow P. B., Pavlou M. Physical disability, life stress, and psychosocial adjustment in multiple sclerosis. Journal of Nervous and Mental Disease 1984; 172: 80–84
  • Zorzon M., Zivadinov R., Nasuelli D., Ukmar M., Bratina A., Tommasi A., et al. Depressive symptoms and MRI changes in multiple sclerosis. European Journal of Neurology 2002; 9: 491–496
  • Zorzon M., de Masi R., Nasuelli D., Ukmar M., Mucelli R. P., Cazzato G., et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. Journal of Neurology 2001; 24: 416–421

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.